Cabaletta Bio (CABA) Payables (2018 - 2025)

Cabaletta Bio's Payables history runs 8 years deep, the most recent figure standing at $6.6 million for Q4 2025.

• On a quarterly basis, Payables rose 34.8% year-over-year to $6.6 million in Q4 2025; TTM through Dec 2025 was $6.6 million, a 34.8% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 34.8% from the prior year.
• Payables declined to $6.6 million in Q4 2025 per CABA's latest filing, from $8.3 million in the prior quarter.
• Across five years, Payables topped out at $8.3 million in Q3 2025 and bottomed at $1.3 million in Q1 2021.
• The 5-year median for Payables is $3.8 million (2022), against an average of $3.9 million.
• Across the five-year window, Payables tumbled 39.78% in 2024 and surged 279.22% in 2025, its largest moves.
• Year by year, Payables stood at $2.3 million in 2021, then rose by 5.57% to $2.5 million in 2022, then surged by 84.61% to $4.5 million in 2023, then climbed by 8.27% to $4.9 million in 2024, then surged by 34.8% to $6.6 million in 2025.
• Per Business Quant, the three latest CABA Payables figures stand at $6.6 million (Q4 2025), $8.3 million (Q3 2025), and $7.2 million (Q2 2025).